investorideas.com / Page 5

Arcus Biosciences (NYSE:RCUS) makes the NYSE top gainer list, up 9.53% on new ARC-20 data for casdatifan in clear cell renal cell carcinoma.

Aamir Iqbal's Daily Gold Trading Report for October 20: spot gold slips toward $4,132 as yields rise, with $4,150 and $4,116 the key intraday levels.

Nigel Green of deVere Group says a Democratic sweep of Congress on 3 November would reshuffle US stock market sectors, hitting AI giants and banks while supporting healthcare.

VisionWave (Nasdaq: VWAV) highlighted its developing RF, radar and electronic-warfare technologies, including VisionRF, GhostSight and DeepWave RF, designed to extend sensing across autonomous systems.

Anna Radomska on the dollar's invalidated weekly breakout and copper testing the lower line of a rising wedge, with the key support and resistance levels.

Monica Kingsley on a short squeeze nipped in the bud, AI build-out worries, hot CPI and PPI versus falling yields, and what breadth says for the S&P 500.

Cleveland-Cliffs (NYSE: CLF) makes the NYSE top gainer list on Q3 results: revenues of $5.6 billion, adjusted EBITDA of $612 million and GAAP net income of $165 million.

Saturn Oil & Gas (TSX: SOIL) makes the TSX top gainer list after agreeing to acquire Corex Resources for $302 million, adding ~7,000 bbl/d of light oil.

GlobalData says Olkiluoto 3 nuclear baseload and fast-growing onshore wind and solar will lift Finland's power capacity to 45.6GW by 2035, with renewables at 76.5%.

deVere CEO Nigel Green warns France's escalating debt and political crisis risks spilling across Europe's bond markets and into global portfolios.